Chongqing Lummy Pharmaceutical Co., Ltd. (300006.SZ)
CNY 5.25
(-2.42%)
CNY 5.25
(-2.42%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.89 Billion CNY | -5.37% |
| 2022 | 3.05 Billion CNY | 4.38% |
| 2021 | 2.92 Billion CNY | -7.02% |
| 2020 | 3.14 Billion CNY | -10.1% |
| 2019 | 3.5 Billion CNY | 11.48% |
| 2018 | 3.14 Billion CNY | 14.61% |
| 2017 | 2.74 Billion CNY | 10.32% |
| 2016 | 2.48 Billion CNY | -19.94% |
| 2015 | 3.1 Billion CNY | 38.28% |
| 2014 | 2.24 Billion CNY | 2.83% |
| 2013 | 2.18 Billion CNY | 53.27% |
| 2012 | 1.42 Billion CNY | 31.71% |
| 2011 | 1.08 Billion CNY | 22.28% |
| 2010 | 884.01 Million CNY | 35.25% |
| 2009 | 653.62 Million CNY | 143.38% |
| 2008 | 268.55 Million CNY | 25.09% |
| 2007 | 214.68 Million CNY | 71.61% |
| 2006 | 125.1 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.97 Billion CNY | 2.96% |
| 2024 Q2 | 2.91 Billion CNY | -2.19% |
| 2024 Q3 | 3.03 Billion CNY | 4.31% |
| 2023 Q1 | 3.08 Billion CNY | 0.94% |
| 2023 FY | 2.89 Billion CNY | -5.37% |
| 2023 Q4 | 2.89 Billion CNY | -0.03% |
| 2023 Q3 | 2.89 Billion CNY | -0.99% |
| 2023 Q2 | 2.92 Billion CNY | -5.29% |
| 2022 FY | 3.05 Billion CNY | 4.38% |
| 2022 Q1 | 3 Billion CNY | 2.79% |
| 2022 Q4 | 3.05 Billion CNY | 0.56% |
| 2022 Q2 | 3 Billion CNY | -0.1% |
| 2022 Q3 | 3.03 Billion CNY | 1.08% |
| 2021 Q3 | 2.97 Billion CNY | -3.69% |
| 2021 Q4 | 2.92 Billion CNY | -1.76% |
| 2021 Q2 | 3.09 Billion CNY | -15.56% |
| 2021 FY | 2.92 Billion CNY | -7.02% |
| 2021 Q1 | 3.66 Billion CNY | 16.37% |
| 2020 Q1 | 3.42 Billion CNY | -2.19% |
| 2020 FY | 3.14 Billion CNY | -10.1% |
| 2020 Q2 | 3.47 Billion CNY | 1.48% |
| 2020 Q3 | 3.6 Billion CNY | 3.68% |
| 2020 Q4 | 3.14 Billion CNY | -12.64% |
| 2019 Q1 | 3.53 Billion CNY | 12.69% |
| 2019 FY | 3.5 Billion CNY | 11.48% |
| 2019 Q2 | 3.6 Billion CNY | 1.88% |
| 2019 Q4 | 3.5 Billion CNY | -2.82% |
| 2019 Q3 | 3.6 Billion CNY | -0.08% |
| 2018 Q4 | 3.14 Billion CNY | 1.41% |
| 2018 FY | 3.14 Billion CNY | 14.61% |
| 2018 Q3 | 3.09 Billion CNY | 2.11% |
| 2018 Q2 | 3.03 Billion CNY | 2.8% |
| 2018 Q1 | 2.95 Billion CNY | 7.67% |
| 2017 Q2 | 2.69 Billion CNY | 3.03% |
| 2017 Q1 | 2.61 Billion CNY | 5.46% |
| 2017 Q3 | 2.85 Billion CNY | 5.75% |
| 2017 Q4 | 2.74 Billion CNY | -3.99% |
| 2017 FY | 2.74 Billion CNY | 10.32% |
| 2016 Q4 | 2.48 Billion CNY | -3.98% |
| 2016 Q3 | 2.58 Billion CNY | 0.26% |
| 2016 Q2 | 2.58 Billion CNY | -0.7% |
| 2016 Q1 | 2.59 Billion CNY | -16.24% |
| 2016 FY | 2.48 Billion CNY | -19.94% |
| 2015 Q2 | 2.55 Billion CNY | 2.99% |
| 2015 Q4 | 3.1 Billion CNY | 24.08% |
| 2015 FY | 3.1 Billion CNY | 38.28% |
| 2015 Q3 | 2.5 Billion CNY | -2.12% |
| 2015 Q1 | 2.48 Billion CNY | 10.55% |
| 2014 Q2 | 2.27 Billion CNY | 1.08% |
| 2014 FY | 2.24 Billion CNY | 2.83% |
| 2014 Q1 | 2.25 Billion CNY | 3.2% |
| 2014 Q3 | 2.2 Billion CNY | -3.1% |
| 2014 Q4 | 2.24 Billion CNY | 1.74% |
| 2013 Q1 | 1.95 Billion CNY | 37.31% |
| 2013 Q2 | 2.04 Billion CNY | 4.6% |
| 2013 FY | 2.18 Billion CNY | 53.27% |
| 2013 Q3 | 2.19 Billion CNY | 7.57% |
| 2013 Q4 | 2.18 Billion CNY | -0.79% |
| 2012 Q3 | 1.41 Billion CNY | 3.02% |
| 2012 Q4 | 1.42 Billion CNY | 0.55% |
| 2012 Q2 | 1.37 Billion CNY | 23.11% |
| 2012 FY | 1.42 Billion CNY | 31.71% |
| 2012 Q1 | 1.11 Billion CNY | 3.27% |
| 2011 Q2 | 1.03 Billion CNY | 8.79% |
| 2011 FY | 1.08 Billion CNY | 22.28% |
| 2011 Q4 | 1.08 Billion CNY | 3.2% |
| 2011 Q3 | 1.04 Billion CNY | 0.84% |
| 2011 Q1 | 954.85 Million CNY | 8.01% |
| 2010 Q1 | 674.02 Million CNY | 3.12% |
| 2010 Q4 | 884.01 Million CNY | 21.63% |
| 2010 FY | 884.01 Million CNY | 35.25% |
| 2010 Q3 | 726.83 Million CNY | 2.86% |
| 2010 Q2 | 706.64 Million CNY | 4.84% |
| 2009 Q2 | 285.7 Million CNY | 0.0% |
| 2009 FY | 653.62 Million CNY | 143.38% |
| 2009 Q4 | 653.62 Million CNY | -2.85% |
| 2009 Q3 | 672.81 Million CNY | 135.5% |
| 2008 Q4 | 268.55 Million CNY | 0.0% |
| 2008 FY | 268.55 Million CNY | 25.09% |
| 2007 FY | 214.68 Million CNY | 71.61% |
| 2006 FY | 125.1 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 13.9 Billion CNY | 79.216% |
| Zhejiang Zhenyuan Share Co., Ltd. | 2.98 Billion CNY | 3.127% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 1.06 Billion CNY | -172.635% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 3.02 Billion CNY | 4.576% |
| Yifan Pharmaceutical Co., Ltd. | 11.49 Billion CNY | 74.861% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 847.56 Million CNY | -241.081% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 36.52 Billion CNY | 92.085% |
| Boai NKY Medical Holdings Ltd. | 4.01 Billion CNY | 28.082% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 2.56 Billion CNY | -12.829% |